US Stock MarketDetailed Quotes

Senti Biosciences (SNTI)

Watchlist
  • 1.0244
  • +0.0614+6.38%
Trading May 14 10:10 ET
31.90MMarket Cap-0.38P/E (TTM)

Senti Biosciences (SNTI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.94%-43.44M
49.09%-6.88M
-20.09%-9.45M
-56.66%-13.07M
-20.27%-14.05M
20.99%-41.4M
-91.90%-13.5M
48.85%-7.87M
38.98%-8.35M
28.35%-11.68M
Net income from continuing operations
-16.38%-61.44M
-2,271.64%-14.47M
37.21%-18.13M
-31.51%-14.73M
-16.52%-14.11M
25.71%-52.79M
96.74%-610K
-93.43%-28.87M
40.08%-11.2M
35.31%-12.11M
Operating gains losses
----
----
----
----
----
74.86%-6.33M
-104.63%-107K
---2.35M
----
----
Depreciation and amortization
-5.24%3.64M
-4.70%893K
-640.74%-200K
0.61%1.48M
0.48%1.47M
-29.31%3.84M
-36.43%937K
-101.49%-27K
21.14%1.47M
57.27%1.46M
Other non cash items
-99.32%39K
--0
--0
----
----
806.02%5.75M
-3,055.45%-13.32M
10,011.11%17.84M
3,043.90%3.62M
-2,594.38%-2.4M
Change In working capital
-41.36%3.56M
121.92%222K
60.90%7.33M
-157.04%-1.38M
-2,516.67%-2.61M
30.14%6.07M
-116.94%-1.01M
881.30%4.56M
175.11%2.42M
106.70%108K
-Change in receivables
129.49%210K
124.11%149K
8,569.57%1.95M
-1,033.85%-1.47M
-800.00%-413K
23.36%-712K
-153.09%-618K
98.93%-23K
-165.33%-130K
143.70%59K
-Change in prepaid assets
-58.04%3.72M
66.18%-1.07M
-27.02%3.02M
-53.37%1.97M
-105.30%-195K
84.71%8.86M
-194.83%-3.18M
186.37%4.14M
948.26%4.21M
1,015.17%3.68M
-Change in payables and accrued expense
1,726.98%2.3M
-56.45%1.42M
7,572.41%2.23M
5.03%-585K
70.20%-762K
-70.42%126K
182.87%3.27M
-93.79%29K
-266.94%-616K
-63.28%-2.56M
-Change in other current assets
13.86%2.29M
15.90%605K
----
----
----
--2.01M
--522K
----
----
----
-Change in other current liabilities
-19.71%-4.65M
-19.09%-1.23M
-29.32%-1.19M
-15.36%-1.13M
-15.54%-1.09M
-902.07%-3.88M
-378.92%-1.03M
0.00%-921K
-742.48%-983K
-207.26%-946K
-Change in other working capital
4.86%-313K
1,552.38%347K
-126.42%-360K
-139.06%-153K
-15.75%-147K
-199.09%-329K
136.21%21K
-127.27%-159K
73.66%-64K
67.60%-127K
Cash from discontinued investing activities
Operating cash flow
-4.94%-43.44M
49.09%-6.88M
-20.09%-9.45M
-56.66%-13.07M
-20.27%-14.05M
20.99%-41.4M
-91.90%-13.5M
48.85%-7.87M
38.98%-8.35M
28.35%-11.68M
Investing cash flow
Cash flow from continuing investing activities
-641.18%-184K
0
0
-184K
0
-99.89%34K
-110.89%-11K
-99.72%60K
0
99.84%-15K
Net PPE purchase and sale
-641.18%-184K
--0
--0
---184K
--0
100.28%34K
-110.89%-11K
103.23%60K
--0
99.77%-15K
Net investment purchase and sale
----
----
----
----
----
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-641.18%-184K
--0
--0
---184K
--0
-99.89%34K
-110.89%-11K
-99.72%60K
--0
99.84%-15K
Financing cash flow
Cash flow from continuing financing activities
-78.11%11.76M
-78.48%11.04M
-94.92%124K
1.01M
-414K
6,797.30%53.73M
9,124.82%51.29M
10,708.70%2.44M
0
0
Net issuance payments of debt
----
----
----
----
----
--0
-10,465.22%-2.43M
10,665.22%2.43M
--0
--0
Net common stock issuance
--0
-101.37%-670K
--136K
----
----
9,481.84%49.06M
23,948.53%49.06M
--0
----
----
Proceeds from stock option exercised by employees
--11.18M
111,900.00%11.18M
----
----
----
--0
---10K
----
----
----
Net other financing activities
-87.56%581K
-76.35%530K
---12K
--477K
---414K
--4.67M
--2.24M
----
----
----
Cash from discontinued financing activities
Financing cash flow
-78.11%11.76M
-78.48%11.04M
-94.92%124K
--1.01M
---414K
6,797.30%53.73M
9,124.82%51.29M
10,708.70%2.44M
--0
--0
Net cash flow
Beginning cash position
31.35%51.82M
12.41%15.78M
29.37%25.11M
34.59%37.35M
31.35%51.82M
-35.32%39.45M
-69.36%14.04M
-51.59%19.41M
-21.05%27.75M
-35.32%39.45M
Current changes in cash
-357.68%-31.87M
-88.97%4.17M
-73.72%-9.32M
-46.75%-12.25M
-23.66%-14.46M
157.42%12.37M
692.08%37.78M
-193.48%-5.37M
-269.03%-8.35M
54.73%-11.7M
End cash Position
-61.50%19.95M
-61.50%19.95M
12.41%15.78M
29.37%25.11M
34.59%37.35M
31.35%51.82M
31.35%51.82M
-69.36%14.04M
-51.59%19.41M
-21.05%27.75M
Free cash flow
-5.35%-43.64M
49.13%-6.88M
-20.09%-9.45M
-59.01%-13.27M
-20.12%-14.05M
35.71%-41.42M
-91.95%-13.52M
54.37%-7.87M
51.89%-8.35M
48.72%-11.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.94%-43.44M49.09%-6.88M-20.09%-9.45M-56.66%-13.07M-20.27%-14.05M20.99%-41.4M-91.90%-13.5M48.85%-7.87M38.98%-8.35M28.35%-11.68M
Net income from continuing operations -16.38%-61.44M-2,271.64%-14.47M37.21%-18.13M-31.51%-14.73M-16.52%-14.11M25.71%-52.79M96.74%-610K-93.43%-28.87M40.08%-11.2M35.31%-12.11M
Operating gains losses --------------------74.86%-6.33M-104.63%-107K---2.35M--------
Depreciation and amortization -5.24%3.64M-4.70%893K-640.74%-200K0.61%1.48M0.48%1.47M-29.31%3.84M-36.43%937K-101.49%-27K21.14%1.47M57.27%1.46M
Other non cash items -99.32%39K--0--0--------806.02%5.75M-3,055.45%-13.32M10,011.11%17.84M3,043.90%3.62M-2,594.38%-2.4M
Change In working capital -41.36%3.56M121.92%222K60.90%7.33M-157.04%-1.38M-2,516.67%-2.61M30.14%6.07M-116.94%-1.01M881.30%4.56M175.11%2.42M106.70%108K
-Change in receivables 129.49%210K124.11%149K8,569.57%1.95M-1,033.85%-1.47M-800.00%-413K23.36%-712K-153.09%-618K98.93%-23K-165.33%-130K143.70%59K
-Change in prepaid assets -58.04%3.72M66.18%-1.07M-27.02%3.02M-53.37%1.97M-105.30%-195K84.71%8.86M-194.83%-3.18M186.37%4.14M948.26%4.21M1,015.17%3.68M
-Change in payables and accrued expense 1,726.98%2.3M-56.45%1.42M7,572.41%2.23M5.03%-585K70.20%-762K-70.42%126K182.87%3.27M-93.79%29K-266.94%-616K-63.28%-2.56M
-Change in other current assets 13.86%2.29M15.90%605K--------------2.01M--522K------------
-Change in other current liabilities -19.71%-4.65M-19.09%-1.23M-29.32%-1.19M-15.36%-1.13M-15.54%-1.09M-902.07%-3.88M-378.92%-1.03M0.00%-921K-742.48%-983K-207.26%-946K
-Change in other working capital 4.86%-313K1,552.38%347K-126.42%-360K-139.06%-153K-15.75%-147K-199.09%-329K136.21%21K-127.27%-159K73.66%-64K67.60%-127K
Cash from discontinued investing activities
Operating cash flow -4.94%-43.44M49.09%-6.88M-20.09%-9.45M-56.66%-13.07M-20.27%-14.05M20.99%-41.4M-91.90%-13.5M48.85%-7.87M38.98%-8.35M28.35%-11.68M
Investing cash flow
Cash flow from continuing investing activities -641.18%-184K00-184K0-99.89%34K-110.89%-11K-99.72%60K099.84%-15K
Net PPE purchase and sale -641.18%-184K--0--0---184K--0100.28%34K-110.89%-11K103.23%60K--099.77%-15K
Net investment purchase and sale ----------------------0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow -641.18%-184K--0--0---184K--0-99.89%34K-110.89%-11K-99.72%60K--099.84%-15K
Financing cash flow
Cash flow from continuing financing activities -78.11%11.76M-78.48%11.04M-94.92%124K1.01M-414K6,797.30%53.73M9,124.82%51.29M10,708.70%2.44M00
Net issuance payments of debt ----------------------0-10,465.22%-2.43M10,665.22%2.43M--0--0
Net common stock issuance --0-101.37%-670K--136K--------9,481.84%49.06M23,948.53%49.06M--0--------
Proceeds from stock option exercised by employees --11.18M111,900.00%11.18M--------------0---10K------------
Net other financing activities -87.56%581K-76.35%530K---12K--477K---414K--4.67M--2.24M------------
Cash from discontinued financing activities
Financing cash flow -78.11%11.76M-78.48%11.04M-94.92%124K--1.01M---414K6,797.30%53.73M9,124.82%51.29M10,708.70%2.44M--0--0
Net cash flow
Beginning cash position 31.35%51.82M12.41%15.78M29.37%25.11M34.59%37.35M31.35%51.82M-35.32%39.45M-69.36%14.04M-51.59%19.41M-21.05%27.75M-35.32%39.45M
Current changes in cash -357.68%-31.87M-88.97%4.17M-73.72%-9.32M-46.75%-12.25M-23.66%-14.46M157.42%12.37M692.08%37.78M-193.48%-5.37M-269.03%-8.35M54.73%-11.7M
End cash Position -61.50%19.95M-61.50%19.95M12.41%15.78M29.37%25.11M34.59%37.35M31.35%51.82M31.35%51.82M-69.36%14.04M-51.59%19.41M-21.05%27.75M
Free cash flow -5.35%-43.64M49.13%-6.88M-20.09%-9.45M-59.01%-13.27M-20.12%-14.05M35.71%-41.42M-91.95%-13.52M54.37%-7.87M51.89%-8.35M48.72%-11.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More